olivLaw · US equity research
Huize Holding Limited HUIZ
Insurance Agents, Brokers & Service · SIC 6411 · Vertical: Insurance Agents, Brokers & Service (SIC 6411)
Huize Holding Limited runs an independent online insurance platform in Asia that distributes products from partner insurers without bearing underwriting risk. In fiscal 2025 the company reported total operating revenue of RMB 1,582.2 million, and rapid growth in Hong Kong suggests a geographic diversification worth monitoring.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Huize Holding Limited (HUIZ) stock was 2.31 USD (+2.21% on the day), with market capitalisation 1.1 bn USD, beta 0.52, 52-week range 1.06–3.62 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 66.3
- strong (55–70)
- Bollinger (20, 2)
- 1.10 – 2.76
- in the upper half of the band · %B 0.73 · band width 86.4%
- SMA 50 / 200
- 1.65 / 1.60
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 0.21 / 0.20
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +76.3% | −1.1% | +77.4 pp | — |
| 3 months | +97.4% | −0.5% | +97.9 pp | — |
| 6 months | +35.9% | +4.4% | +31.5 pp | — |
| Year to date | −17.8% | +12.3% | −30.1 pp | — |
| 1 year | −39.5% | +13.5% | −53.1 pp | +0.8% |
| 3 years | −49.2% | +76.4% | −125.6 pp | +4.3% |
| 5 years | −75.8% | +63.7% | −139.5 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | unavailable | 142.7 m | 187.0 m | 352.3 m | 167.9 m | 168.4 m | 171.1 m | 226.3 m |
| Revenue YoY | unavailable | unavailable | +31.1% | +88.4% | −52.3% | +0.3% | +1.6% | +32.2% |
| Net income | unavailable | 2.1 m | -2.8 m | -16.9 m | -4.5 m | 9.9 m | -89.0 k | 578.0 k |
| Net income YoY | unavailable | unavailable | −230.9% | unavailable | unavailable | unavailable | −100.9% | unavailable |
| Diluted EPS | unavailable | unavailable | unavailable | unavailable | 0.00 | 0.01 | 0.00 | 0.00 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | −100.0% | unavailable |
| net % | unavailable | 1.5% | -1.5% | -4.8% | -2.7% | 5.9% | -0.1% | 0.3% |
| Free cash flow | unavailable | 16.1 m | 19.8 m | -33.6 m | -14.8 m | 15.0 m | -3.2 m | 1.4 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 35.9 m USD
- Financial debt
- 8.6 m USD
- Net debt
- -27.3 m USD
- Equity
- 61.8 m USD
- Total assets
- 134.2 m USD
- Debt / equity
- 0.14x
- Current ratio
- 1.44x
- ROE
- 1.0%
- ROA
- 0.5%
- FCF margin
- 0.6%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 187.0 m | 352.3 m | 167.9 m | 168.4 m | 171.1 m | 226.3 m | SEC (XBRL)· 24 Apr 2026verified |
| Cost of revenue | 124.7 m | 264.9 m | 605.7 m | 647.4 m | 796.9 m | 1.1 bn | SEC (XBRL)· 24 Apr 2026verified |
| Gross profit | 62.3 m ≈ | 87.4 m ≈ | -437.9 m ≈ | -479.0 m ≈ | -625.8 m ≈ | -871.6 m ≈ | SEC (XBRL)· 24 Apr 2026derived |
| Research & development | 7.5 m | 18.9 m | 11.7 m | 10.1 m | 8.5 m | 8.4 m | SEC (XBRL)· 24 Apr 2026verified |
| Operating income | -4.0 m | -18.0 m | -6.3 m | 7.2 m | -2.9 m | 952.0 k | SEC (XBRL)· 24 Apr 2026verified |
| Depreciation & amortisation | 783.0 k | 1.2 m | 2.7 m | 1.9 m | 1.6 m | 2.0 m | SEC (XBRL)· 24 Apr 2026verified |
| EBITDA | -3.2 m ≈ | -16.8 m ≈ | -3.7 m ≈ | 9.1 m ≈ | -1.3 m ≈ | 2.9 m ≈ | SEC (XBRL)· 24 Apr 2026derived |
| Pre-tax income | -16.5 m | -107.7 m | -33.7 m | -70.6 m | 834.0 k | -10.8 m | SEC (XBRL)· 24 Apr 2026verified |
| Income tax | 271.0 k | 0 | 0 | 0 | 18.0 k | 1.0 m | SEC (XBRL)· 24 Apr 2026verified |
| Net income | -2.8 m | -16.9 m | -4.5 m | 9.9 m | -89.0 k | 578.0 k | SEC (XBRL)· 24 Apr 2026verified |
| Diluted EPS | — | — | 0.00 | 0.01 | 0.00 | 0.00 | SEC (XBRL)· 24 Apr 2026verified |
| Weighted average diluted shares | 963.8 m | 1.0 bn | 1.0 bn | 1.0 bn | 997.2 m | 1.0 bn | SEC (XBRL)· 24 Apr 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue; Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 62.0 m | 59.8 m | 40.2 m | 35.1 m | 31.9 m | 35.9 m | SEC (XBRL)· 24 Apr 2026verified |
| Receivables | 35.6 m | 122.0 m | 36.3 m | 25.1 m | 21.5 m | 24.7 m | SEC (XBRL)· 24 Apr 2026verified |
| Current assets | 154.5 m | 222.9 m | 108.8 m | 85.4 m | 82.1 m | 94.2 m | SEC (XBRL)· 24 Apr 2026verified |
| Property, plant & equipment, net | 1.6 m | 7.6 m | 5.6 m | 7.6 m | 6.5 m | 5.5 m | SEC (XBRL)· 24 Apr 2026verified |
| Goodwill | 71.0 k | 72.0 k | 67.0 k | 65.0 k | 2.0 m | 2.0 m | SEC (XBRL)· 24 Apr 2026verified |
| Intangibles (excl. goodwill) | 311.0 k | 3.4 m | 7.8 m | 7.1 m | 9.4 m | 9.4 m | SEC (XBRL)· 24 Apr 2026verified |
| Total assets | 204.7 m | 291.5 m | 158.0 m | 133.4 m | 121.1 m | 134.2 m | SEC (XBRL)· 24 Apr 2026verified |
| Accounts payable | 34.9 m | 106.8 m | 38.0 m | 29.8 m | 27.7 m | 27.9 m | SEC (XBRL)· 24 Apr 2026verified |
| Short-term debt | 31.5 m | 216.7 m | 150.0 m | 30.0 m | 6.9 m | 7.6 m | SEC (XBRL)· 24 Apr 2026verified |
| Long-term debt | 8.3 m | 3.1 m | 0 | — | — | 1.0 m | SEC (XBRL)· 24 Apr 2026verified |
| Current liabilities | 85.3 m | 191.8 m | 81.1 m | 55.6 m | 56.9 m | 65.6 m | SEC (XBRL)· 24 Apr 2026verified |
| Total liabilities | 132.9 m | 234.8 m | 108.4 m | 75.6 m | 62.3 m | 72.4 m | SEC (XBRL)· 24 Apr 2026verified |
| Equity | 71.8 m † | 56.6 m | 49.6 m | 57.8 m | 58.8 m | 61.8 m | SEC (XBRL)· 24 Apr 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 21.1 m | -27.6 m | -12.3 m | 19.3 m | -2.6 m | 2.6 m | SEC (XBRL)· 24 Apr 2026verified |
| Capex | 1.3 m | 6.0 m | 2.4 m | 4.3 m | 587.0 k | 1.2 m | SEC (XBRL)· 24 Apr 2026verified |
| Free cash flow | 19.8 m ≈ | -33.6 m ≈ | -14.8 m ≈ | 15.0 m ≈ | -3.2 m ≈ | 1.4 m ≈ | SEC (XBRL)· 24 Apr 2026derived |
| Investing cash flow | -4.8 m | -12.7 m | -8.2 m | -8.6 m | -445.0 k | -1.7 m | SEC (XBRL)· 24 Apr 2026verified |
| Financing cash flow | 58.7 m | 22.3 m | -14.7 m | -18.8 m | 3.2 m | 588.0 k | SEC (XBRL)· 24 Apr 2026verified |
| Share repurchases | 316.0 k | 471.0 k | 965.0 k | 1.9 m | 11.0 k | 0 | SEC (XBRL)· 24 Apr 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 46 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 1.1 bn USD
Key indicators
Coverage and freshness
Score by group
- Balance sheet87
- Growth87
- Quality54
- Returns0
- Valuation1
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 0.12 – 0.15 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDA0.12 – 0.15 (Mid 0.14)4 companies used · median multiple 13.7x · quartiles 11.2x – 15.1xBWIN, GSHD, MRSH, SLQT
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 46/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 2.3% | 36 (vs peers) | 15% |
| Net margin · Quality | 0.3% | 38 (vs peers) | 9% |
| FCF conversion · Quality | 238.1% | 100 (on a fixed band) | 9% |
| Revenue CAGR 3Y · Growth | 10.5% | 87 (on a fixed band) | 12% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | -9.3x | 100 (vs peers) | 15% |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 1.4x | 53 (on a fixed band) | 6% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | 371.9x | 0 (vs peers) | 15% |
| FCF yield · Valuation | 0.1% | 2 (on a fixed band) | 12% |
| Shareholder yield (distributions) · Returns | 0.0% | 0 (on a fixed band) | 9% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet87/100 · 2/3 factors with a value
- Growth· partial87/100 · 1/2 factors with a value
- Quality54/100 · 3/3 factors with a value
- Returns· partial0/100 · 1/2 factors with a value
- Valuation1/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Huize Holding Limited (HUIZ). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 226.3 m USD in 2025; YoY growth 32.2%; net margin 0.3%; ROE 1.0%; net debt/EBITDA -9.3x.
The estimated value range is 0.12–0.15 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 0.14 USD, the price of 2.31 USD leaves a potential of -94.0% (value / price − 1) and a margin of safety of -1,556.6% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 46/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: growth, returns. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- FCF conversion: 238.1%
- Revenue CAGR 3Y: 10.5%
- Net debt / EBITDA: -9.3x
What contradicts it
- EV/EBITDA: 371.9x
- FCF yield: 0.1%
- Shareholder yield (distributions): 0.0%
- The price is above the estimated value range
Not assessed (insufficient data or a ratio without meaning): EPS CAGR 3Y, Interest coverage, P/E (TTM), Payout ratio (FCF).
Versus the vertical median
Insurance Agents, Brokers & Service (SIC 6411) · same industry (4-digit SIC) · compared with 29 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| MRSHMarsh & Mclennan Companies, Inc. | 100.0 bn | 25.2 | 26.7% | 14.2% | +10.3% | +15% / +5% |
| XHGXChange TEC.INC | 85.9 bn | — | — | -204.9% | +24.9% | +253% / −100% |
| AJGArthur J. Gallagher & Co. | 73.9 bn | 47.1 | 6.7% | 10.0% | +20.7% | +16% / +16% |
| AONAon plc | 73.1 bn | 18.9 | 43.6% | 22.2% | +9.4% | −3% / +5% |
| WTWWillis Towers Watson PLC | 31.1 bn | 20.5 | 20.2% | 15.2% | −2.2% | +5% / +37% |
| BROBrown & Brown, Inc. | 24.5 bn | 22.1 | 9.7% | 17.6% | +22.8% | −8% / −1% |
| EQHEquitable Holdings, Inc. | 15.3 bn | — | -508.8% | -8.7% | −6.1% | +20% / +83% |
| AIFUAIFU Inc. | 10.5 bn | — | -155.9% | -408.8% | −67.9% | −84% / −100% |
| ACTEnact Holdings, Inc. | 6.6 bn | 10.7 | 12.7% | 53.8% | +2.8% | +25% / +74% |
| HGTYHagerty, Inc. | 6.5 bn | 108.0 | 25.6% | 4.4% | +17.3% | +40% / +121% |
| RYANRyan Specialty Holdings, Inc. | 5.2 bn | 49.9 | 19.4% | 3.2% | +21.3% | −18% / +4% |
| CRVLCorvel Corporation | 4.4 bn | 38.9 | 30.7% | 11.7% | +7.0% | +19% / +26% |
| WDHWaterdrop Inc. | 3.6 bn | 50.5 | 11.6% | 14.2% | +49.8% | −44% / −16% |
| ARXAccelerant Holdings | 3.3 bn | — | -241.6% | -112.1% | +51.5% | +36% / unavailable |
| NPNeptune Insurance Holdings Inc. | 2.7 bn | 91.6 | — | 22.7% | +33.7% | +22% / unavailable |
| GSHDGoosehead Insurance, Inc. | 1.2 bn | 33.8 | — | 8.8% | +16.2% | −21% / −23% |
| HUIZHuize Holding Limited | 1.1 bn | — | 1.0% | 0.3% | +32.2% | −40% / −49% |
| BWINThe Baldwin Insurance Group, Inc. | 1.1 bn | — | -10.7% | -4.7% | +8.3% | +13% / +84% |
| RDZNRoadzen Inc. | 92.8 m | — | — | -46.9% | +24.2% | −37% / −78% |
| SLQTSelectQuote, Inc. | 88.1 m | 7.3 | 23.4% | 4.6% | +6.0% | −66% / −61% |
| EHTHeHealth, Inc | 20.3 m | — | 5.0% | 5.4% | +4.1% | −84% / −91% |
| EZRAReliance Global Group, Inc. | 2.4 m | — | -123.4% | -54.3% | −11.6% | −91% / −100% |
| YBYuanbao Inc. | — | — | 152.7% | 29.9% | +33.1% | −43% / unavailable |
| ERIEErie Indemnity Company | — | — | 23.7% | 14.0% | +7.2% | −5% / −5% |
| HITHealth In Tech, Inc. | — | — | -21.9% | -12.0% | +71.0% | −61% / unavailable |
1- and 3-year price returns: for HUIZ from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 0.02 Total return -99% · Per year -99% | 0.04 Total return -98% · Per year -98% | 0.06 Total return -97% · Per year -97% |
| 3 years | 0.02 Total return -99% · Per year -78% | 0.05 Total return -98% · Per year -73% | 0.08 Total return -97% · Per year -68% |
| 5 years | 0.03 Total return -99% · Per year -59% | 0.06 Total return -97% · Per year -52% | 0.10 Total return -95% · Per year -46% |
- Exit P/E± 0.01
- Net margin± 0.01
- Annual revenue growth± 0.01
- Annual dilution± 0.00
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 24 Apr 2026; since then the company filed 6-K (20 Aug 2026), 6-K (20 May 2026).
In brief
Huize Holding Limited runs an independent online insurance platform in Asia that distributes products from partner insurers without bearing underwriting risk. In fiscal 2025 the company reported total operating revenue of RMB 1,582.2 million, and rapid growth in Hong Kong suggests a geographic diversification worth monitoring.
SWOT
Strengths
- The platform has a large client base and a broad product portfolio, supported by a network of partner insurers.
- Revenue is concentrated in life and health products, which provide recurring premiums and higher commissions.
- Intermediary licences in China and Singapore support the company's credibility with clients and partners.
Weaknesses
- Reliance on the VIE contractual framework limits direct control over operations in China.
- Client acquisition costs through traffic channels are high and can compress margins.
- The company has recorded operating and net losses in the past and has not consistently remained profitable.
Opportunities
- Expansion in Southeast Asia could add new revenue sources if the Global Care integration succeeds.
- Growing demand for personalised insurance planning could support growth in life products.
- Diversifying insurer partners could reduce dependence on a few large providers.
Threats
- Regulatory changes to commissions could reduce income from life and non-auto products.
- Risks tied to the VIE structure and government policy could affect the value of an investment.
- Competitive pressure from online platforms and offline intermediaries could limit growth.
Risks
- VIE structurehigh
Investors hold shares in a Cayman Islands company, not in the China operating entity, and if authorities find the contractual arrangements non-compliant, operations could be severely affected.
- Commission regulationhigh
Limits on commissions for life and non-auto insurance could directly reduce brokerage income.
- Dependence on partner insurersmedium
If some partners reduce their cooperation or face operational difficulties, revenue could fall, especially given concentration.
- Audit and US listingmedium
HFCAA provisions could lead to a prohibition on trading the ADSs in the United States if auditor inspections cannot be completed.
- ADS price volatilitymedium
The trading price of the ADSs has been volatile and may continue to fluctuate, exposing investors to significant losses.
Investment thesis
What would need to be true (bull case)
- Revenue growth in 2025 and the focus on life and health products could support a recovery in profitability if margins improve.
- Expansion into Singapore and Vietnam could open new markets and reduce dependence on mainland China.
- A large base of younger clients and a broad network of partner insurers could strengthen the company's long-term position.
What would break the thesis
- Commission caps imposed by the regulator could directly reduce revenue from the highest-yielding products.
- The VIE structure and political risks in China could lead to a loss of control over operations.
- A history of losses and high acquisition costs could prevent the company from achieving stable profitability.
What to watch
- Trend in margins and client acquisition costsnext 10-K
- Application of new commission rules for life insurance2027
- Contribution of Global Care and Singapore activity to revenuenext 10-K
- Trend in revenue concentration among the five largest insurer partners2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 24 Apr 2026; since then the company filed 6-K (20 Aug 2026), 6-K (20 May 2026).
The business
Huize Holding Limited, known in its filings as an independent online insurance product and service platform, operates as a licensed intermediary. It earns revenue mainly from brokerage and agency fees paid by its insurer partners, which underwrite the policies sold. Operations in mainland China are largely conducted through the VIE structure based on contractual arrangements, because foreign ownership limits apply.
The platform includes the websites www.huize.com and www.qixin18.com, the « Huize Insurance » mobile app and official WeChat accounts, and insurance consultants who provide assistance and personalised planning. The company focuses on younger clients, with an average age of 35.3 for life and health insurance buyers in 2025, and works with 158 insurer partners as of December 31, 2025.
In September 2024 the international arm Poni Insurtech acquired a majority stake in Global Care of Vietnam, and in July 2025 it obtained a licence from the Monetary Authority of Singapore for Poni Financial Advisory. These steps extend activity across ASEAN, but their contribution to consolidated results remains to be seen.
Segments
Life and health insurance
The life and health segment generated 90.4% of brokerage income in 2025, with annuity and endowment life products and long-term health insurance. Commission rates are generally higher than on property and casualty products, and periodic premium payments provide a relatively steady income flow.
Property and casualty insurance
The property and casualty segment includes travel, individual casualty and corporate insurance products, with a smaller share of revenue. Its contribution rose in 2025, and these products are also distributed through the xiebao18.com website.
Market context
China's online insurance market is still developing, and the regulatory framework changes often, including adjustments to commission rates paid through distribution channels. Hong Kong reached 47.7% of operating revenue in 2025, showing rapid expansion but also growing reliance on a market other than mainland China.
Foreign ownership restrictions on online business and insurance brokerage drive the use of the contractual structure, while Southeast Asia is a new growth direction through Singapore and Vietnam. Growth in these markets depends on regulatory approvals and the company's ability to attract clients.
Trends
- Stricter commission regulationheadwind
The insurance regulator has limited commissions on long-term life and non-auto insurance, which could reduce brokerage income. The company has stated that its activity in these segments may be affected.
- Focus on life and health insurancetailwind
Demand for customised products and long-term planning could support revenue, since life products carry higher commissions and recurring premiums.
- Expansion in Southeast Asiatailwind
The Singapore licence and the Global Care acquisition open access to growing markets, if integration and local regulation proceed as planned.
- Reliance on user traffic channelsmixed
Fees paid to traffic channels to acquire clients remain high, and regulatory changes affecting these channels could weigh on acquisition efficiency.
Competitive position
The company competes with other online insurance platforms and offline intermediaries in China, in a fragmented market where clients can compare products easily. Differentiation rests on its broad product range, personalised consulting and relationships with insurers.
Relationships with a large number of insurers and the ability to develop tailored products are key competitive factors. Pressure on acquisition costs could rise if marketing becomes more expensive.
- Online insurance platforms in China
Competitors distributing insurance over the internet with similar commission models from insurers.
- Offline insurance intermediaries
Agents and brokers with physical networks competing for the same life and health clients.
- Insurance platforms in Southeast Asia
Companies active in Singapore and Vietnam, where Huize is expanding through its subsidiaries.
- Insurers selling directly online
Insurance companies that distribute their own products directly, reducing the role of intermediaries.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report (foreign issuer)20 Aug 2026
- Current report (foreign issuer)20 May 2026
- Annual report (foreign issuer)24 Apr 2026
- Current report (foreign issuer)27 Mar 2026
- Current report (foreign issuer)06 Mar 2026
- Current report (foreign issuer)22 Dec 2025
- Current report (foreign issuer)26 Nov 2025
- Current report (foreign issuer)02 Oct 2025
- Current report (foreign issuer)12 Sept 2025
- Current report (foreign issuer)09 Jun 2025
Sources
- [1] Form 20-F, fiscal year ended 2025-12-31 · SEC / Huize Holding Limited · 24 Apr 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.